ISR — ISR Immune System Regulation Holding AB (publ) Share News
0.000.00%
HealthcareHighly SpeculativeMicro Cap
Brief: ISR Immune System Regulation Holding H1 Net Loss Narrows To SEK 8.9 Million
Brief: ISR Holding Starts New Subsidiary
Brief: ISR Q4 Operating Loss Narrows To SEK 4.9 Million
Brief: ISR Starts Two New Programs Against TBC And Cancer
Brief: Swedish drug maker ISR to launch phase IIa study
Brief: ISR Q3 operating loss at SEK 3.7 million
Brief: ISR appoints Ola Winqvist new CEO
Brief: ISR Immune System Regulation Holding Q2 operating loss widens to SEK 4.6 mln
Brief: ISR signs to cooperate with China Resources Development Group